Dividend Hunter Finds Value At Tekla Life Sciences

Tekla Life Sciences (HQL) is a closed-end fund (CEF) managed by Tekla Capital Management; the fund invests in biotech industry stocks with up to 40% of the portfolio invested in pre-public (“venture”) companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.